key: cord-0733864-hule2fh9
authors: Ozsurekci, Yasemin; Aykac, Kubra; Bal, Fatma; Bayhan, Cihangul; Basaranoglu, Sevgen T.; Alp, Alpaslan; Cengiz, Ali Bulent; Kara, Ates; Ceyhan, Mehmet
title: Outcome predictors of influenza for hospitalization and mortality in children
date: 2021-02-09
journal: J Med Virol
DOI: 10.1002/jmv.26833
sha: 4f0b79583117deea769a3f0d492885efc5b38543
doc_id: 733864
cord_uid: hule2fh9

Severity of disease caused by influenza virus and the influencing factors that may be different. Moreover, the disease course actually may not be determined specifically in children because of lower seroprotection rates of children. Herein, the results clinic and outcome data of children with influenza from Turkey were reported. We present here the results from 2013 to 2017. Nasopharyngeal swab samples of the children with influenza were investigated via multiplex polymerase chain reaction. A total of 348 children were diagnosed with influenza; 143 (41.1%) were influenza A, 85 (24.4%) were influenza B, and 120 (34.5%) were mixt infection with other respiratory viruses. Fifty‐four percent of children admitted to intensive care unit (ICU) were under 2 years of age (p = .001). Having an underlying disease was detected as the main predictor for both hospitalization and ICU stay according to multiple logistic regression analysis (odds ratio [OR], 11.784: 95% confidence interval [CI], 5.212–26.643; p = .001 and OR, 4.972: 95% CI, 2.331–10.605; p = .001, respectively). Neurological symptoms most frequently seen in cases who died (44.4%; p = .02). Lymphopenia was relatively higher (55.6%) and thrombocytopenia was most frequently seen in cases who died (77.8%) with a significant ratio (p = .001). Underlying diseases was found a risk factor for influenza being hospitalized and being admitted to ICU. Children under 2 years of age and with underlying diseases should be vaccinated particularly in countries where the influenza vaccination is still not routinely implemented in the immunization schedule. Highlights Underlying diseases is a risk factor for influenza to be hospitalized and admitted to ICU. Influenza vaccination is of great importance to prevent life‐threatening complications of influenza, particularly in children require ICU admission. The possibility to reduce the outpatient visit number by vaccination has a great impact on disease burden in addition to the underestimated crucial social benefits, as well.

The two influenza viruses, A and B, cause epidemics in humans and they are one of the main reasons of morbidity and mortality due to a virus in worldwide. An estimated 5%-10% of adults and 20%-30% of children are infected with influenza virus despite a significant variation of illness rates in year-to-year, which causing 3-5 million severe cases besides 250,000 to 500,000 deaths annually. [1] [2] [3] [4] Although many of infections have mild clinical course, requiring no hospital admission, a proportion of cases present with severe complications, mainly in people with underlying health conditions and in young children and the elderly. 3 A couple of risk factors have been found to be associated with intensive care unit (ICU) admission and mortality in hospitalized cases 3, 5 ; there are scarce data from Turkey, particularly from children. Investigating and understanding those factors associated with poor outcomes might be crucial to prepare health resources accurately. 6, 7 The aim of this study was to investigate factors associated with hospitalization, ICU admission, and death in children infected with influenza. Patients with influenza infection were classified into four groups as (1) intensive care unit (ICU) group; severe patients who required admission to an ICU, 8 (2) non-ICU group; patients who did not need an ICU stay, (3) ex-patients; patients who died during the treatment were included in the assessment as infection-related mortality if the death had been caused by the infection, 9 and (4) outpatients; patients who were followed in outpatient clinics that did not need hospitalization. Variables for which the p value was less than .20 in bivariate analysis were included in a full multiple logistic model according the magnitude of their effect. In all the analysis, p < .05 was considered significant.

Total of 348 children infected with influenza virus were enrolled in this retrospective study during 4 years period. Nasopharyngeal swabs were collected from all the patients. We compared patients among four groups as patients (n = 33) who admitted to ICU, patients (n = 195) who hospitalized to pediatric inpatient clinics except ICU, patients (n = 9) who died, and patients (n = 111) who did not need hospitalization and were followed in outpatient clinics. The most patients were males (53.7%) and the median age of the cases were 3 years (min-max, 0-17). No statistically significant differences were found between the groups in terms of gender (p = .30) and overall age (p = .11). However, the distribution of cases under 2 years of age according to groups were 54.5%, 43.1%, 33.3%, and 20.7%, respectively (p = .001; Table 1 ). There was no any statistically significance between the groups in terms of the distribution of cases infected with influenza A and B as well as mixt viral infection (p = .32). Overall mixt viral infection ratio was 34.5% and the most coinfected viruses were RSV, followed by rhinovirus, influenza A and B, and bocavirus ( Figure 1 ). Mixt viral infection ratio was relatively higher in cases who died (Table 1) and the most coinfected virus was RSV ( Table 2 ). The most commonly clinical diagnosis of the cases who died were pneumonia and myocarditis ( Table 2) .

In ICU group, 27.3% of patients had no underlying diseases, the most frequent underlying disease was cardiac conditions (15.2%). In non-ICU group, 51.8% of patients had no underlying disease, the most frequent underlying disease was malignancies (11.8%). In exitus group (n = 9), three patients (33.3%) who died and in outpatient group, 89.2% of cases had no any underlying conditions. Fever and respiratory symptoms were most significantly seen in outpatients (p = .001 in each). Neurological symptoms most frequently seen in cases who died (44.4%, n = 4) with a significant ratio as compared with other groups (p = .02; Table 1 ).

Although no statistically significant differences were found between the groups in terms of white blood cell (WBC; p = .05), neutropenia (p = .46), and lymphopenia (p = .37), lymphopenia was relatively higher (55.6%) in cases who died as compared with the other groups. In addition, thrombocytopenia was most frequently seen in cases who died (77.8%) with a significant ratio as compared the others (p = .001). 

Influenza virus is an important cause of respiratory illness among children. Children younger than two years of age have a high hospitalization and complication ratio because of the infections caused by influenza virus [11] [12] [13] as in our study. More than 50% of children admitted to ICU were under 2 years of age in the current study.

Many children with influenza have commonly some clinical symptoms including fever, cough, and rhinorrhea. Poehling et al. 14 reported that children younger than 6 months of age have significantly lower cough and fever and cough ratio as compared with children aged 6-59 months of age. In outpatient setting of the present study, the most common symptoms were fever and respiratory symptoms with the ratios more than 90% consistently with the literature. 14 Vice versa, fever response and respiratory symptoms were not significantly seen in inpatients as compared with the outpatients. Given that RSV, which cause influenza-like illness and pneumonia is the most common co-infecting virus in the cases who died in the current study and impose a substantial burden of hospitalization, which was estimated to cause 60%-80% more deaths than influenza in one study from England and Wales. 18, 19 Goka et al. 20 reported that co-infection is a significant predictor of disease outcome and rhinovirus and RSV were the most coinfected viruses in this study as in our study. Therefore, the effects of these coinfecting viruses on the prognosis of the patient should not be ignored as well.

The annual rates of hospitalization attributable to influenza have ranged from 0.6 to 2.7 per 1000 children younger than 5 years of age. 11 condition to be hospitalized in ICU in the present study. Flannery et al. 24 reported that more than one-half of the pediatric deaths in their study had one or more underlying medical condition with the severe influenza-associated complications. Therefore, American

Academy of Pediatrics recommend a special effort to vaccinate individuals with chronic medical conditions which increase the risk of complications caused by influenza, including pulmonary, metabolic, and cardiac diseases, immunosuppression, renal, hepatic, and neurologic disorders. 25 Therefore, these data may give a valuable information to shed light on the situation of pre-vaccine era in countries such as Turkey.

Second, we could not perform a cost analysis to reveal the actual burden of the disease, which might lead us realize the real impact of the virus from a detailed perspective in the world without vaccines.

As a conclusion, influenza illnesses cause a substantial health burden despite the many clinically unrecognized cases infected with influenza virus; therefore, since testing is not routinely performed in every center in Turkey, influenza testing is one of the major steps to increase the awareness of the physicians as well as public. Increased use of rapid testing may improve infection-control activities and increase the need for influenza vaccine as mentioned in literature. 14 The other important step is prevention; that is, influenza vaccination reduces life-threatening influenza in children require ICU admission. 32 When the realities of Turkey taken into consideration, particularly children under 2 years of age and children with underlying diseases should be driven to be vaccinated on account of the high hospitalization rates with a high ICU admission as a first step on the way of national immunization. In addition, although the vaccination against influenza in children has been primarily dependent on the ratio of hospitalization from a logical perspective, reducing the outpatient visit number via vaccination would have a great impact on disease burden with the underestimated crucial social benefits. 33 

The authors declare that there are no conflict of interests.

Yasemin Ozsurekci: study design, manuscript writing, and review.

Kubra Aykac: study design, data collection, and manuscript writing. 

Epidemiology, seasonality and treatment of hospitalized adults and adolescents with influenza in

Influenza (seasonal)

Risk factors associated with severe outcomes in adult hospitalized patients according to influenza type and subtype

Influenza (including Avian Influenza and Swine Influenza)

Prospective comparative study of characteristics associated with inflluenza A and B in adults

Epidemiological features of influenza in Canadian adult intensive care unit patients

Distribution of influenza virus types by age using case-based global surveillance data from twenty-nine countries

Respiratory viral infections in infants with possible sepsis

Intensive-Care Unit Admissions and Deaths -California

Myocarditis associated with influenza infection in five children

The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children

Influenza and the rates of hospitalization for respiratory disease among infants and young children

influenza season

The underrecognized burden of influenza in young children

Can the mild clinical course of Crimean-Congo hemorrhagic fever in children be explained by cytokine responses

Severe influenza among children and young adults with neurologic and neurodevelopmental condirions-Ohio

Neuroinfluenza: evaluation of seasonal influenza associated severe neurological complications in children (a multicenter study)

Impact of influenza and respiratory syncytial virus on mortality in England and Wales from

Estimates of hospitalization attributable to influenza and RSV in the US during 1997-2009, by age and risk status

Influenza A viruses dual and multiple infections with other respiratory viruses and risk of hospitalization and mortality. Influenza Other Respir Viruses

Influenza-associated hospitalizations in the United States

Incidence of outpatient visits and hospitalizations related to influenza in infants and young children

Influenza vaccine effectiveness against pediatric deaths

Clinical Research Committee on Mycarditis Associated with 2009 Influenza A (H1N1) pandemic in Japan organized by Japanese Circulation Society. A national survey on myocarditis associated with the 2009 influenza A (H1N1) pandemic in Japan

Influenza vaccination in Turkey: prevalence of risk groups, current vaccination status, factors influencing vaccine uptake and steps taken to increase vaccination rate

Influenza and pneumonia vaccination rates in patients hospitalized with acute respiratory failure

Infleunza vaccination prevalence among the elderly and individuals with chronic disease, and factors affecting vaccination uptake

Seasonal influenza vaccine effectiveness in preventing laboratory confirmed influenza in 2014-2015 season in Turkey; a test-negative case control study

Influenza epidemiology and influenza vaccine effectiveness during the 2016-2017 season in the Global Influenza Hospital Surveillance Network (GIHSN)

Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. Effectiveness of influenza vaccine against life-threatening RT-PCR-confirmed influenza illness in US children

An economic analysis of annual influenza vaccination of children

Outcome predictors of influenza for hospitalization and mortality in children

The data that support the findings of this study are available from the corresponding author upon reasonable request.

http://orcid.org/0000-0001-8662-6909Kubra Aykac http://orcid.org/0000-0002-0974-4765